Mehdi Namdar

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

The quantification of absolute myocardial perfusion in humans by contrast echocardiography

Rolf Vogel, Andreas Indermühle, Jessica S. Reinhardt et al. · Journal of the American College of Cardiology · 2005 · 252 citations

Contrast Echocardiography, Cardiovascular Disease, Myocardial Infarction +10

An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease

Aleš Linhart, Dominique P. Germain, Iacopo Olivotto et al. · European Journal of Heart Failure · 2020 · 212 citations · Full text

Integrated PET/CT for the assessment of coronary artery disease: a feasibility study.

Mehdi Namdar, Thomas F. Hany, Pascal Koepfli et al. · PubMed · 2005 · 195 citations

Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up

Gian‐Battista Chierchia, G. Di Giovanni, Giuseppe Ciconte et al. · EP Europace · 2014 · 154 citations · Full text